首页|抑制巨噬细胞移动抑制因子联合沉默PCSK9减轻ApoE-/-小鼠动脉粥样硬化

抑制巨噬细胞移动抑制因子联合沉默PCSK9减轻ApoE-/-小鼠动脉粥样硬化

扫码查看
目的 探讨在沉默前蛋白转换酶枯草溶菌素9(PCSK9)的基础上,应用巨噬细胞移动抑制因子(MIF)抑制剂,对ApoE-/-小鼠动脉粥样硬化(AS)的综合治疗作用.方法 将ApoE-/-小鼠普食饲养6个月建立AS模型.PCSK9si组小鼠经尾静脉注射 2 × 1011 vg/只 AAV8.2-Lbcpf-CrRNA2.PCSK9si+ISO-1 组小鼠经尾静脉注射 2 × 1011 vg/只 AAV8.2-Lbcpf-CrRNA2,同时经腹腔注射5mg/(kg·d)MIF抑制剂ISO-1.对照组小鼠(无治疗干预).AS模型期间分别于0、2、4、6个月进行内眦静脉采血检测PCSK9、MIF水平.AS建模6个月后采血检测血清血脂四项及白细胞介素1β(IL-1β)水平,流式细胞术检测循环Ly-6Chigh促炎单核细胞水平;全主动脉以及窦部取材,组织学检测斑块面积,纤维化及脂质浸润程度,CD68(巨噬细胞标志物)及核因子κB(NF-κB)p65蛋白在脂质斑块的表达.STRING数据库检索PCSK9与MIF的蛋白互作关系.结果 与对照组相比,总胆固醇水平在PCSK9si组及PCSK9si+ISO-1组分别降低49%和44%;低密度脂蛋白水平下降54%和52%(P均<0.000 1);甘油三酯水平降低25%和27%(P均<0.05);高密度脂蛋白胆固醇水平升高93%和77%(P均<0.01).血清PCSK9水平在PCSK9si组及PCSK9si+ISO-1组分别降低59%和46%;MIF水平下降28%和44%.PCSK9si组的Ly-6Chigh促炎单核细胞百分比和血浆IL-1β水平无显著差异,而PCSK9si+ISO-1组Ly-6Chigh促炎单核细胞百分比和血浆IL-1β分别降低50%和48.4%(P均<0.05).PCSK9si组及 PCSK9si+ISO-1 组主动脉 AS 斑块面积分别减少 16%(P>0.05)和 31.2%(P<0.05),主动脉窦的斑块面积分别减少20%和46.9%(P均<0.05),主动脉窦部斑块内的天狼星红染色阳性区面积分别减少23.6%(P>0.05)和57.3%(P<0.05).蛋白互作分析显示MIF通过趋化因子受体4(CXCR4)及表皮细胞生长因子(EGF)与PCSK9发生交互作用.结论 在沉默PCSK9的基础上,应用MIF抑制剂ISO-1可显著减轻ApoE-/-小鼠AS病变程度.
Inhibition of Macrophage Migration Inhibition Factor Combined with PCSK9 Silencing Attenuates Atherosclerosis in ApoE-/-Mice
Objective To investigate the comprehensive therapeutic effect of macrophage migration inhibition factor(MIF)inhibitor on ApoE-/-mouse atherosclerosis(AS)based on the silencing of Pro-protein convertase subtilisin/kexin 9(PCSK9).Methods ApoE-/-mice were fed general diet for 6 months to establish AS model.Mice in PCSK9si group were injected with 2 × 1011 vg/AAV8.2-Lbcpf-CrRNA2 via tail vein.Mice in PCSK9si+ISO-1 group were injected with 2 × 1011 vg/AAV8.2-Lbcpf-CrRNA2 via caudal vein,while mice in control group were intraperitoneally injected with 5mg/kg/d MIF inhibitor ISO-1(without therapeutic intervention).Blood samples were collected from the internal canthal vein at 0,2,4,and 6 months during the AS model to detect the levels of PCSK9 and MIF.After 6 months of modeling,blood samples were collected to detect serum lipids and interleukin 1β(IL-1β)levels.Flow cytometry was used to detect circulating Ly-6Chigh proinflammatory mononuclear cells.The plaque area,fibrosis and lipid infiltration,and the expression of CD68(macrophage marker)and nuclear factor κB(NF-κB)p65 protein in the lipid plaques were determined histologically.The protein interaction between PCSK9 and MIF was retrieved in STRING database.Results Compared with the control group,the total cholesterol level in PCSK9si group and PCSK9si+ISO-1 group was reduced by 49%and 44%,respectively;low density lipoprotein levels decreased by 54%and 52%(both P<0.000 1);triglyceride levels were reduced by 25%and 27%(both P<0.05);high density lipoprotein cholesterol levels increased by 93%and 77%(both P<0.01).Serum PCSK9 levels in PCSK9si group and PCSK9si+ISO-1 group were reduced by 59%and 46%,respectively.MIF levels fell by 28%and 44%.The percentage of Ly-6Chigh pro-inflammatory monocytes and plasma IL-1β in PCSK9si group were not significantly different,while the percentage of Ly-6Chigh proinflammatory monocytes and plasma IL-1β in PCSK9si+ISO-1 group were reduced by 50%,respectively(both P<0.05)and 48.4%(both P<0.05).Aortic AS plaque area decreased by 16%(P>0.05)and 31.2%in PCSK9si and PCSK9si+ISO-1 groups,respectively(P<0.05),the aortic sinus plaque area was reduced by 20%and 46.9%,respectively(both P<0.05),the area of Sirius red staining positive area in aortic sinus plaques decreased by 23.6%(P>0.05)and 57.3%,respectively(P<0.05).Protein interaction analysis showed that MIF interacts with PCSK9 through chemokine receptor 4(CXCR4)and epidermal cell growth factor(EGF).Conclusion On the basis of silencing PCSK9,the application of MIF inhibitor ISO-1 can significantly reduce the degree of AS lesions in ApoE-/-mice.

Proprotein convertase subtilisin 9Macrophage migration inhibitory factorAtherosclerosisInflammatory cytokines

余小林、房彬彬、刘芬、李文玲、陈邦党、高晓明、杨毅宁

展开 >

新疆维吾尔自治区人民医院心内科,乌鲁木齐 830001

新疆心血管稳态与再生研究重点实验室,乌鲁木齐 830054

新疆医科大学临床医学研究院,乌鲁木齐 830054

新疆心血管重点实验室,乌鲁木齐 830054

新疆医学动物模型研究重点实验室,乌鲁木齐 830054

展开 >

前蛋白转化酶枯草溶菌素9 巨噬细胞移动抑制因子 动脉粥样硬化 炎症细胞因子

国家自然基金面上项目新疆自治区自然科学基金项目

820703682023D01C91

2024

中国分子心脏病学杂志
中国医学科学院,中国协和医学院

中国分子心脏病学杂志

CSTPCD
影响因子:0.426
ISSN:1671-6272
年,卷(期):2024.24(1)
  • 39